115 related articles for article (PubMed ID: 8016994)
1. [Offer for better drug information].
Højgaard L
Ugeskr Laeger; 1994 Feb; 156(6):832-3. PubMed ID: 8016994
[No Abstract] [Full Text] [Related]
2. Hotel-based medicine.
Greenwald R
J Rheumatol; 2009 Feb; 36(2):456; author reply 456-7. PubMed ID: 19208583
[No Abstract] [Full Text] [Related]
3. A prescription for better prescriptions.
Woosley RL
Issues Sci Technol; 1994; 10(3):59-66. PubMed ID: 10133487
[No Abstract] [Full Text] [Related]
4. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
Rosenthal M
J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239
[No Abstract] [Full Text] [Related]
5. [Pro medicine or pro pharma?].
Schroll JB
Ugeskr Laeger; 2013 Nov; 175(48):2968-9. PubMed ID: 26504924
[No Abstract] [Full Text] [Related]
6. Role of information and of decision-making in the field of supply and consumption of medical preparations.
Kis GS
Sante Publique (Bucur); 1980; 23(2):73-80. PubMed ID: 7209743
[No Abstract] [Full Text] [Related]
7. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
Morgan S; Mintzes B; Barer M
J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759
[TBL] [Abstract][Full Text] [Related]
8. Regulating manufacturer-affiliated communication in the information age.
Schulman KA; Abernethy DR; Rathore SS; Woosley RL
Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
[No Abstract] [Full Text] [Related]
9. Better communication urged for pharmaceutical manufacturers.
Woods D
Can Med Assoc J; 1984 Jun; 130(11):1488-9. PubMed ID: 6733620
[No Abstract] [Full Text] [Related]
10. Pharmaceutical companies should offer reliable information, not freebies.
Hulstrand EP
Am J Hosp Pharm; 1989 Apr; 46(4):702. PubMed ID: 2719046
[No Abstract] [Full Text] [Related]
11. [The fight for existence].
Haug C
Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1817. PubMed ID: 12830248
[No Abstract] [Full Text] [Related]
12. Quality of drug information service provided by pharmaceutical manufacturers.
Doyal LE
Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090
[No Abstract] [Full Text] [Related]
13. [How to improve drug information!].
Järhult B
Lakartidningen; 1998 Jul; 95(30-31):3278-9. PubMed ID: 9715057
[No Abstract] [Full Text] [Related]
14. Is drug advertising informing the consumer?
Hanlon PM
Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141
[No Abstract] [Full Text] [Related]
15. [Pharmacological information and the drug industry. The role of its medical departments].
Castillo Pérez P
Med Clin (Barc); 1987 Sep; 89(7):288-95. PubMed ID: 3316871
[No Abstract] [Full Text] [Related]
16. How to ask drug companies for help.
Hayes JD
Am J Nurs; 1993 Jan; 93(1):38-41. PubMed ID: 8447345
[No Abstract] [Full Text] [Related]
17. [Scrutiny of drug marketing by drug industry].
Perman E
Lakartidningen; 2003 Apr; 100(16):1444-5. PubMed ID: 12756713
[No Abstract] [Full Text] [Related]
18. Information from drug companies and opinion leaders.
Liberati A; Magrini N
BMJ; 2003 May; 326(7400):1156-7. PubMed ID: 12775588
[No Abstract] [Full Text] [Related]
19. A standard of knowledge for pharmaceutical sales representatives.
Bootman JL
Manag Care Interface; 2006 Oct; 19(10):13. PubMed ID: 17117593
[No Abstract] [Full Text] [Related]
20. Direct-to-consumer prescription drug advertising.
Terzian TV
Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
